Literature DB >> 8739682

The intraocular pressure lowering effect of timolol in gel-forming solution.

E F Rosenlund.   

Abstract

The effect on the intraocular pressure (IOP) of 0.5% timolol solution given twice daily was compared to 0.5% timolol in gel-forming solution given once daily. Patients (n = 223) having an IOP of above 22 mmHg were recruited from 16 eye specialist centres in Scandinavia and Finland. The patients were randomized to two treatment groups, timolol solution treatment and timolol in gel-forming solution treatment. Eyes with and without pseudoexfoliation were included. The patients were stratified regarding the presence or not of pseudoexfoliation, to ensure appropriate distribution of this condition. No difference in intraocular pressure reducing effect was registered for the two groups. The pressure reducing effect of the two modes of treatment was not affected by the presence or not of pseudoexfoliation. The study also included registration of local and systemic signs and symptoms possibly related to the study medications. Blurring of vision occurred more often in patients given 0.5% timolol in gel-forming solution compared to timolol solution. The heart rate decreased statistically significantly in patients given timolol solution, but not in patients given timolol in gel-forming solution. This study suggests that treatment with 0.5% timolol in gel-forming solution once a day may be equally as good as 0.5% timolol solution given twice a day in patients with glaucoma both with and without pseudoexfoliation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739682     DOI: 10.1111/j.1600-0420.1996.tb00062.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  2 in total

1.  Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system.

Authors:  Indu Pal Kaur; Deepika Aggarwal; Harinder Singh; Shilpa Kakkar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-02       Impact factor: 3.117

2.  Ocular hypotensive efficacy and safety of once daily carteolol alginate.

Authors:  P Demailly; C Allaire; C Trinquand
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.